[HTML][HTML] RBM10: structure, functions, and associated diseases
A Inoue - Gene, 2021 - Elsevier
RBM10 is a nuclear RNA-binding protein (RBP) that regulates the alternative splicing of
primary transcripts. Recently, research on RBM10 has become increasingly active owing to …
primary transcripts. Recently, research on RBM10 has become increasingly active owing to …
Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells
M Chimonidou, G Kallergi, V Georgoulias… - Molecular Cancer …, 2013 - AACR
Breast cancer metastasis suppressor-1 (BRMS1) differentially regulates the expression of
multiple genes, leading to metastasis suppression without affecting orthotopic tumor growth …
multiple genes, leading to metastasis suppression without affecting orthotopic tumor growth …
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes
R Piazza, D Ramazzotti, R Spinelli, A Pirola… - Scientific reports, 2017 - nature.com
The complicated, evolving landscape of cancer mutations poses a formidable challenge to
identify cancer genes among the large lists of mutations typically generated in NGS …
identify cancer genes among the large lists of mutations typically generated in NGS …
[HTML][HTML] RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway
R Ma, LN Zhao, H Yang, YF Wang, J Hu… - American journal of …, 2018 - ncbi.nlm.nih.gov
Radioresistance is an important obstacle to nasopharyngeal carcinoma (NPC) therapy. In
this study, we explored the role of RNA-binding motif protein 3 (RBM3) in the radioresistance …
this study, we explored the role of RNA-binding motif protein 3 (RBM3) in the radioresistance …
[HTML][HTML] Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation
X Huo, S Li, T Shi, A Suo, Z Ruan, H Guo, Y Yao - Oncotarget, 2015 - ncbi.nlm.nih.gov
Metastasis is the leading cause of death in breast cancer (BC) patients. However, until now,
the mechanisms of BC metastasis remain elusive. Cullin3 is a highly conserved Cullin family …
the mechanisms of BC metastasis remain elusive. Cullin3 is a highly conserved Cullin family …
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis
LM Cook, X Cao, AE Dowell, MT Debies… - Clinical & experimental …, 2012 - Springer
Morbidity and mortality of breast cancer patients are drastically increased when primary
tumor cells are able to spread to distant sites and proliferate to become secondary lesions …
tumor cells are able to spread to distant sites and proliferate to become secondary lesions …
Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma
SJ Pang, Z Sun, WF Lu, H Si-Ma, ZP Lin… - Cancer Management …, 2023 - Taylor & Francis
Background RBM10ʹ s function in hepatocellular carcinoma (HCC) has rarely been
addressed. We intend to explore the prognostic significance and therapeutic meaning of …
addressed. We intend to explore the prognostic significance and therapeutic meaning of …
[HTML][HTML] 非小细胞肺癌组织中RBM3 的表达及其与患者预后的相关性研究
黄东帅, 田金, 郭成业 - Advances in Clinical Medicine, 2023 - hanspub.org
目的: 探讨RBM3 (RNA 结合基序蛋白3, RNA binding motif protein 3) 在非小细胞肺癌(Non-
Small Cell Lung Cancer, NSCLC) 组织中的表达情况及其与患者临床病理学参数和预后的关系 …
Small Cell Lung Cancer, NSCLC) 组织中的表达情况及其与患者临床病理学参数和预后的关系 …
[HTML][HTML] 乳腺癌转移抑制基因1 在消化系肿瘤中的研究进展
黄先达, 路明亮, 黄华 - 世界华人消化杂志, 2012 - wjgnet.com
乳腺癌转移抑制基因1 (breast cancer metastasis suppressor 1, BRMS1) 是2000
年在乳腺癌细胞中发现的一种肿瘤转移抑制基因, 他可降低肿瘤细胞的转移潜能 …
年在乳腺癌细胞中发现的一种肿瘤转移抑制基因, 他可降低肿瘤细胞的转移潜能 …
Correlation analysis of RBM3 expression in tumor stroma and prognosis of patients with non-small cell lung cancer
L Chen, D Ling, Y Chen, K Gai, Y Liu, C Guo, T Zhang - 2019 - researchsquare.com
Objective: To investigate the correlation between the expression of RNA binding motif
protein 3 (RBM3) in non-small cell lung cancer (NSCLC) pathological tissue and known risk …
protein 3 (RBM3) in non-small cell lung cancer (NSCLC) pathological tissue and known risk …